Samantha Budd Haeberlein

Samantha Budd Haeberlein is a trustee at The Boston Home, a nursing-care facility for adults with physical disabilities, primarily multiple sclerosis and other progressive neurological diseases. Samantha has held this position for 6 years and 9 months.

Previously, they worked at Biogen for 7 years and 5 months, where they were the SVP, Head Neurodegeneration Development Unit and Vice President Clinical Development.

Before that, they worked at AstraZeneca for 15 years, where they were the Vice President Neuroscience Virtual Business Unit, Head Translational Sciences, Global Program Lead, Vice President & Head of Translational Science, Director, Neurology Disease Area Leader, and Discovery Research.

Samantha is also a member of the board of the Stockholm Brain Institute, where they have served for 4 years.

Samantha Budd Haeberlein has a PhD from The University of Dundee and a BSc (Hons) 1st class from the same school. Samantha did their post doc and instructor work at Harvard Medical School from 1997 to 1999.